asimov.com

Website review asimov.com

Asimov — Intelligent Design

 Generated on March 30 2026 15:19 PM

Old data? UPDATE !

The score is 56/100

SEO Content

Title

Asimov — Intelligent Design

Length : 27

Perfect, your title contains between 10 and 70 characters.

Description

Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.

Length : 154

Great, your meta description contains between 70 and 160 characters.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
type website

Headings

H1 H2 H3 H4 H5 H6
1 87 80 0 0 0
  • [H1] Intelligent designof living systems
  • [H2] Enabling the design and manufacture of advanced therapies
  • [H2] Our approach
  • [H2] How to work with us
  • [H2] Two ways to work with us
  • [H2] Built by genetic designers, for biotech builders
  • [H2] Supported by top investors and US research agencies
  • [H2] Partnered with over 25 companies, from small biotechs to big pharma
  • [H2] In the press
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Launches RNA Edge, a Lab-in-the-Loop Platform for AI Optimization of RNA Therapeutic Candidates
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Asimov Launches CHO Edge Rapid Pools to Bridge Biologics Discovery and CMC with Predictive Stable Expression
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Optimizing Bispecific Antibody Expression with Amgen
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Launches Stable AAV Producer Cell Lines, Setting a New Standard for Viral Vector Manufacturing
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Announces Cell Line Development Partnership with Ottimo Pharma to Accelerate Cancer Immunotherapy’s Path to Clinic
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Enters into Agreement with BARDA's BioMaP Consortium to Advance Production of Medical Countermeasures Against Ebola and Deadly Viruses
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Asimov Announces IND Approval and Clinical Dosing of Bispecific Antibody Produced Using CHO Edge Expression System
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] Cytiva and Asimov collaborate on next generation cell line design and process development
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] LOTTE BIOLOGICS and Asimov Announce Partnership for Accelerated Cell Line Development And Scaling to GMP Manufacturing
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Novo Nordisk license CHO Edge System
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Asimov launches LV Edge Packaging System to optimize lentivirus production
  • [H2] Announcing Asimov Press
  • [H2] Announcing Asimov Press
  • [H2] Asimov Labs
  • [H2] Asimov Labs
  • [H2] Lift Off
  • [H2] Lift Off
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov to Present Data on AI-Designed Tissue Specific Promoters at Upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov Partners With iGEM to Support the Next Generation of Synthetic Biologists
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov and Center for Breakthrough Medicines Form Strategic Partnership for Viral Vector Production
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Asimov Raises $200 Million to Advance Therapeutics Design and Manufacturing with Synthetic Biology
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Drug Manufacture Has One Huge Flaw. This Synthetic Biology Startup Just Raised $200m To Fix It.
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] Asimov Selected by DARPA to Develop Artificial Intelligence Design Engine for Synthetic Biology
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Startup Exchange Names Asimov to STEX25
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] MIT Spinout Asimov Implements Programming Language for Cells
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] How Programmable DNA Strands Could Control Healing
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] The automatic-design tools that are changing synthetic biology
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] Biologists would love to program cells as if they were computer chips
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] How Cambridge Startup Asimov Is Doing Business With 'Genetic Circuits'
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Bio-programming toolkit maker Asimov launches with $4.7M from Andreessen Horowitz
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Andreessen Horowitz leads seed round in MIT-born 'genetic circuits' startup
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz
  • [H2] Asimov
  • [H2] Asimov
  • [H2] Cellular Circuit Computes with DNA
  • [H2] Cellular Circuit Computes with DNA
  • [H2] A programming language for living cells
  • [H2] A programming language for living cells
  • [H2] We're hiring at the intersection of biology, engineering, and machine learning.
  • [H3] Biologics
  • [H3] Cell Therapies
  • [H3] Gene Therapies
  • [H3] Host cells
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] Host cell lines
  • [H3] Genetic parts library
  • [H3] Design software
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] We perform services in our lab
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] We provide tools for you to develop a cell line
  • [H3] We develop a cell line for you
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We transfer our platform to your lab
  • [H3] We develop a cell line for you
  • [H3] We ship you host cells and grant software access
  • [H3] You design DNA
  • [H3] We ship DNA to you
  • [H3] You perform cell line development
  • [H3] You request producer cells
  • [H3] We do cell line development
  • [H3] We share progress
  • [H3] We ship you producer cell banks
  • [H3] We perform services in our lab
  • [H3] We provide tools for you to develop a cell line
  • [H3] You design DNA
  • [H3] We build DNA
  • [H3] You transfect cells
  • [H3] You request a stable cell line
  • [H3] We perform cell line and process development
  • [H3] We collaborate and share progress
  • [H3] We ship you clonal, stable cell lines
  • [H3] Everything you need
  • [H3] From our lab to yours
  • [H3] We use our own platform every day

Images

We found 285 images on this web page.

214 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 11%

This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

Perfect! No underscores detected in your URLs.

In-page links

We found a total of 4 links including 0 link(s) to files

Anchor Type Juice
Biologics Internal Passing Juice
Cell Therapies Internal Passing Juice
Gene Therapies Internal Passing Juice
Sign up Internal Passing Juice

SEO Keywords

Keywords Cloud

more asimov software design line cells development blog cell read

Keywords Consistency

Keyword Content Title Keywords Description Headings
cell 113
more 86
asimov 85
read 79
line 79

Usability

Url

Domain : asimov.com

Length : 10

Favicon

Great, your website has a favicon.

Printability

We could not find a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Great, your website has few CSS files.
Too bad, your website has too many JS files (more than 6).
Perfect, your website takes advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://www.asimov.com/sitemap.xml

Robots.txt

https://asimov.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Great, your website has an analytics tool.

   Google Analytics

PageSpeed Insights

Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.